IART: Integra LifeSciences Holdings Corporation Company Sales Revenue

Diversification between neurosurgery and tissue regeneration protects Integra LifeSciences (IART) from regulatory shifts, as evidenced by the company's annual sales volume. The value of 1.66 captures the current state of the parameter. Business stability relies on the implementation of energy-efficient plants and eco-friendly packaging, as well as overcoming geopolitical barriers in electronics supplies and the protection of international patents.

Revenue and Sales Volume: Integra LifeSciences Holdings Corporation (IART) for 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for Integra LifeSciences Holdings Corporation (IART)

- current price and projected stock value:

Share Price Integra LifeSciences Inc.|IART - Consensus Target

- market capitalization information:

Market Value Integra LifeSciences Holdings Corporation|IART - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share Integra LifeSciences|IART - Book Capitalization|Market-to-Book Ratio integralife.com|IART - Company Total Assets

- company liabilities and liquidity data:

Debt to Equity Ratio Integra LifeSciences|IART - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Integra LifeSciences Corp|IART - Company Aggregate Debts|Debt to Book Value Integra LifeSciences Holdings Corporation|IART - Company Long-Term Debts|Company Short-Term Debts Integra LifeSciences|Quick Liquidity integralife.com

- company profitability and valuation multiples indicators:

IART - Net Income|Expected Net Income Integra LifeSciences|IART - P/E Multiple|Projected Price to Earnings Ratio integralife.com|IART - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple Integra LifeSciences Holdings Corporation|IART - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Integra LifeSciences|IART - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months integralife.com|IART - Earnings per share growth in current year|Net earnings per share change forecast for next year Integra LifeSciences

- company sales and revenue statistics:

IART - Company Revenue|Company Future Sales Volume Integra LifeSciences Inc.|IART - P/S Multiple|Market Cap to Future Revenue Ratio Integra LifeSciences Holdings Corporation

Summary company analysis:IART Integra LifeSciences Inc.

This metric measures daily cash inflows from counterparties, neutralizing reporting time lags to assess real demand. This metric allows investors to track liquidity in real time. For Integra LifeSciences (IART), the high scalability of its patented implants transforms innovation into a stable cash cow. Analyzing the revenue dynamics from the company's product sales reveals the efficiency of mass production. The growing trend confirms the fundamental resilience of the business.

Key competitors